Recent Updates
Recently added Catalysts
IART Negative Sentiment Score: 30/100

INTEGRA LIFESCIENCES SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Integra LifeSciences Holdings Corporation - IART

Key Takeaway: The article alerts investors regarding a class action lawsuit against Integra LifeSciences Holdings Corporation stemming from alleged failures to disclose material information during a specific Class Period. The company recalled medical devices due to serious manufacturing issues, significantly impacting its financial forecasts. Following the announcement, Integra's shares suffered a notable decline, highlighting the market's reaction to the company's legal and operational challenges. Investors have until November 13, 2023, to file lead plaintiff applications in this lawsuit.

Market Sentiment Analysis

CONCERNS & RISKS

  • Integra LifeSciences is facing a class action lawsuit for failing to disclose material information.
  • The company recalled medical device products due to a significant deviation from good manufacturing practices.
  • There was a substantial drop in share price, plummeting 20% following the news of the recall.
  • The company adjusted its revenue guidance downward by 6% and earnings per share by 26%.

Full Press Release Details

NEW ORLEANS, Sept. 26, 2023 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until November 13, 2023 to file lead plaintiff applications in a securities class action lawsuit against Integra LifeSciences Holdings Corporation (NasdaqGS: IART), if they purchased the Company’s shares between March 11, 2019 and May 22, 2023, inclusive (the “Class Period”). This action is pending in the United States District Court for the District of New Jersey.
Integra investors should visit us at https://claimsfiler.com/cases/nasdaq-iart/ or call toll-free (844) 367-9658. Lawyers at Kahn Swick & Foti, LLC are available to discuss your legal options.
Integra and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws.
On May 23, 2023, the Company disclosed that it was recalling all medical device products made at its Boston Facility between March 1, 2018 and May 22, 2023 due to a deviation from good manufacturing practices in testing for bacterial endotoxin and the release of products with higher levels of endotoxins, as well as an extended halt on production. As a result, the Company lowered its 2Q 2023 revenue guidance by 6% and adjusted earnings per diluted share by 26% and disclosed an expected $22 million impairment charge due to the inventory write-off.
On this news, shares of Integra plummeted $10.24 per share, or 20%, from a closing price of $50.72 per share on May 22, 2023, to a closing price of $40.48 per share on May 23, 2023.
The case is Pembroke Pines Firefighters & Police Officers Pension Fund v. Integra LifeSciences Holdings Corporation, No. 23-cv-20321.
ClaimsFiler has a single mission: to serve as the information source to help retail investors recover their share of billions of dollars from securities class action settlements. At ClaimsFiler.com, investors can: (1) register for free to gain access to information and settlement websites for various securities class action cases so they can timely submit their own claims; (2) upload their portfolio transactional data to be notified about relevant securities cases in which they may have a financial interest; and (3) submit inquiries to the Kahn Swick & Foti, LLC law firm for free case evaluations.
To learn more about ClaimsFiler, visit www.claimsfiler.com.

Tags

Frequently Asked Questions

What is the deadline to file lead plaintiff applications?

The deadline to file lead plaintiff applications is November 13, 2023.

What time period does the class action cover?

The class action covers shares purchased between March 11, 2019, and May 22, 2023.

Why did Integra's shares drop in May 2023?

Shares dropped due to a recall of medical devices and lowered revenue guidance.

Who should investors contact for more information?

Investors should contact ClaimsFiler or call toll-free at 844-367-9658.

Which law firm is associated with this case?

The law firm Kahn Swick & Foti, LLC is associated with this case.

Last updated: Sep 27, 2023